Loading stock…

Straumann Holding AG (STMN) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Straumann Holding AG

STMNMarket cap $18BPrice $111.3

Country🇨🇭Switzerland

SectorHealthcare

IndustryHealthcare Equipment

Makes dental implants, clear aligners, and tooth replacement systems that dentists use to rebuild smiles worldwide. Straumann controls roughly a quarter of the global implant market, making it the biggest name in a niche most patients never think about until they need it.

In Bastion Portfolios?

52W Return+3%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+9%7

Revenue Forecast

Rev CAGR (1y)+1%3

Rev CAGR (3y)+9%6

Rev CAGR (5y)+9%7

Earnings Forecast

EPS Growth Y+1+45%9

EPS Growth Y+2+15%8

EPS Growth Y+3+13%7

Quality

Margins

EBIT Margin25%8

Net Income Margin14%7

Free Cash Flow Margin14%7

Debt

Net Debt/EBITDA0.19

Efficiency

ROE17%7

ROA10%8

Earnings Stability77

GEAR+STRONG68

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)263

P/E Ratio (Forward 3y)223

P/BV6.53

EV Multiples

EV/EBITDA Fwd173

EV/EBIT Fwd204

Yield

Free Cash Flow Yield2.6%4

Dividend Yield1.1%3

Momentum

Short term

1 month return-0%8

3 month return-13%3

YTD return+0%5

Mid term

Price vs 52wHigh84%6

1 year return+6%5

Long term

3 year return-17%2

5 year return-43%2

Risk Shield

Price Risk

Beta1.23

Volatility31%7

Free Cash Flow

Free Cash Flow Margin14%7

Free Cash Flow Yield2.6%4

Quality

ROCE23%9

Earnings Stability77

Net Debt/EBITDA0.19

02Growth

Is it actually growing, and how fast?

STMNStraumann Holding

Revenue FY25$2.8B

GROWTH RATING↗

AVERAGE59 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+9%7

Revenue, next 1Y+1%3

Revenue, next 3Y, CAGR+9%6

Revenue, next 5Y, CAGR+9%7

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+45%9

EPS growth, FY27E+15%8

EPS growth, FY28E+13%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 9%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

The runway holds up: revenue is set to grow 9%/yr over five years.7/10

Earnings are set to grow faster than sales (EPS about 15%/yr vs revenue 9%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 59% of companies worldwide.

Revenue is set to grow 9%/yr over the next 3 years, in line with the market.5/10

Revenue grew 9%/yr over the last 3 years and is set to keep growing around 9%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

STMNStraumann Holding

Total return Current284%

Price return Current263%

MOMENTUM RATING↗

WEAK30 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-0%8

3-month return-13%3

YTD return+0%5

MID & LONG-TERM▾SCORE

% of 52-week high84%6

1-year return+6%5

3-year return-17%2

5-year return-43%2

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+0%).

WATCH

It's up 6% over the past year, but 16% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level so far this year (+0%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-17% over three years and -43% over five), behind 80% of the market.

The stock is underperforming over three months (-13%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Straumann. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

STMNStraumann Holding

Revenue FY25$2.8B

GROWTH RATING↗

AVERAGE59 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+9%7

Revenue, next 1Y+1%3

Revenue, next 3Y, CAGR+9%6

Revenue, next 5Y, CAGR+9%7

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+45%9

EPS growth, FY27E+15%8

EPS growth, FY28E+13%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 9%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

The runway holds up: revenue is set to grow 9%/yr over five years.7/10

Earnings are set to grow faster than sales (EPS about 15%/yr vs revenue 9%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 59% of companies worldwide.

Revenue is set to grow 9%/yr over the next 3 years, in line with the market.5/10

Revenue grew 9%/yr over the last 3 years and is set to keep growing around 9%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

STMNStraumann Holding

Total return Current284%

Price return Current263%

MOMENTUM RATING↗

WEAK30 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-0%8

3-month return-13%3

YTD return+0%5

MID & LONG-TERM▾SCORE

% of 52-week high84%6

1-year return+6%5

3-year return-17%2

5-year return-43%2

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+0%).

WATCH

It's up 6% over the past year, but 16% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level so far this year (+0%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-17% over three years and -43% over five), behind 80% of the market.

The stock is underperforming over three months (-13%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Straumann. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community